376P - Preclinical evaluation of the anti-CLDN18.2 antibody, IMAB362, in pancreatic carcinoma

Autor: Heinz, C. 1, Mitnacht-Kraus, R. 1, Kreuzberg, M. 1, Wöll, S. 1, Sahin, U. 2, Türeci, Ö. 1
Zdroj: In Annals of Oncology September 2017 28 Supplement 5:v125-v126
Databáze: ScienceDirect